Insiders · MTEM

Jonathan Lanfear

Director at Molecular Templates, Inc. (MTEM)

Jonathan Lanfear has filed 2 insider reports with the SEC since June 2022, as director at Molecular Templates, Inc. (MTEM). The latest filing, on October 31, 2023, reports grant or award at Molecular Templates, Inc. (MTEM).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Jonathan Lanfear is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Molecular Templates, Inc. logo
MTEM
Molecular Templates, Inc.
DirectorOct 31, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Jonathan Lanfear with

Questions about Jonathan Lanfear

What is Jonathan Lanfear's role at Molecular Templates, Inc.?
Jonathan Lanfear reports to the SEC as director at Molecular Templates, Inc. (MTEM), according to the latest filing on October 31, 2023.
Has Jonathan Lanfear bought or sold stock recently?
No open-market purchases or sales by Jonathan Lanfear are on file. The filings report grant or award.
How do I get alerts when Jonathan Lanfear files?
Follow Jonathan Lanfear on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jonathan Lanfear (SEC CIK 0001742858). Totals count each trade once, skipping amendments whose original is on file, from Jun 6, 2022 on. View on SEC EDGAR · Get this as JSON